You just read:

Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies

News provided by

Carmine Therapeutics

29 Aug, 2019, 04:04 BST